Home Cart 0 Sign in  
X

[ CAS No. 620-08-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 620-08-6
Chemical Structure| 620-08-6
Chemical Structure| 620-08-6
Structure of 620-08-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 620-08-6 ]

Related Doc. of [ 620-08-6 ]

Alternatived Products of [ 620-08-6 ]

Product Details of [ 620-08-6 ]

CAS No. :620-08-6 MDL No. :MFCD00674049
Formula : C6H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :XQABVLBGNWBWIV-UHFFFAOYSA-N
M.W : 109.13 Pubchem ID :69278
Synonyms :

Calculated chemistry of [ 620-08-6 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 30.73
TPSA : 22.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.26 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.53
Log Po/w (XLOGP3) : 1.0
Log Po/w (WLOGP) : 1.09
Log Po/w (MLOGP) : 0.13
Log Po/w (SILICOS-IT) : 1.4
Consensus Log Po/w : 1.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.64
Solubility : 2.53 mg/ml ; 0.0231 mol/l
Class : Very soluble
Log S (Ali) : -1.05
Solubility : 9.65 mg/ml ; 0.0884 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.09
Solubility : 0.891 mg/ml ; 0.00817 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 620-08-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H227-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 620-08-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 620-08-6 ]
  • Downstream synthetic route of [ 620-08-6 ]

[ 620-08-6 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 620-08-6 ]
  • [ 4045-24-3 ]
Reference: [1] European Journal of Organic Chemistry, 2009, # 9, p. 1327 - 1334
[2] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1984, p. 737 - 744
  • 2
  • [ 620-08-6 ]
  • [ 626-64-2 ]
Reference: [1] Synthetic Communications, 2011, vol. 41, # 12, p. 1852 - 1857
[2] Heterocycles, 1993, vol. 36, # 2, p. 323 - 328
  • 3
  • [ 620-08-6 ]
  • [ 75-16-1 ]
  • [ 24103-75-1 ]
Reference: [1] Patent: EP1731518, 2006, A1, . Location in patent: Page/Page column 16
  • 4
  • [ 620-08-6 ]
  • [ 33631-09-3 ]
Reference: [1] Patent: WO2011/78984, 2011, A1,
  • 5
  • [ 620-08-6 ]
  • [ 109613-93-6 ]
Reference: [1] Tetrahedron, 1993, vol. 49, # 37, p. 8373 - 8380
  • 6
  • [ 620-08-6 ]
  • [ 74133-20-3 ]
Reference: [1] Biochemistry, 2010, vol. 49, # 49, p. 10421 - 10439
  • 7
  • [ 110-89-4 ]
  • [ 620-08-6 ]
  • [ 2767-90-0 ]
Reference: [1] Chemical Communications, 2018, vol. 54, # 73, p. 10324 - 10327
  • 8
  • [ 620-08-6 ]
  • [ 1815-99-2 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 21, p. 6711 - 6714
  • 9
  • [ 620-08-6 ]
  • [ 17217-57-1 ]
YieldReaction ConditionsOperation in experiment
32 %Spectr. at 140℃; for 18 h; Inert atmosphere Under a nitrogen atmosphere, palladium acetate (11.2 mg, 0.05mmol), 1, 10 - phenanthroline (49.6 mg, 0.25mmol), silver acetate (250 mg, 1.5mmol), (1 ml) was suspended in pyridine (51.1 mg, 0.5mmol) pivalic acid, stirred at 140 °C 26 hours. After the reaction mixture was cooled to room temperature, the insoluble matter was removed by filtration over celite, methylene chloride (10 ml) was washed. The filtrate was concentrated under reduced pressure, 1, 1, 2, 2 - tetrachloroethane (15.8 μl, 0.15mmol) was added as an internal standard substance was obtained residue,1H NMR (88percent) yield was calculated based oxidizing agent. (Methylene chloride/hexane=5/95) to give a residue for a thin layer chromatography analysis, the subject compound (quantitative value NMR 89percent, 80percent isolated yield) was obtained as a white powder 93.1 mg.
Reference: [1] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14830 - 14835
[2] Journal of the American Chemical Society, 2007, vol. 129, # 36, p. 11006 - 11007
[3] Organometallics, 2012, vol. 31, # 13, p. 4817 - 4831
[4] Organometallics, 2016, vol. 35, # 14, p. 2348 - 2360
[5] Patent: JP2017/132738, 2017, A, . Location in patent: Paragraph 0083; 0090; 0091; 0100-0102
  • 10
  • [ 620-08-6 ]
  • [ 31872-62-5 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: at 70℃; for 60 h;
To cone. H2SO4 (5 mL) chilled in an ice bathm is added 4-methoxypyridine (0.5 mL, 4.9 mmol) dropwise over a 20 s period. Cone. Fuming nitric acid (5 mL) is added, and the reaction mixture is heated at 70 °C for 2.5 days. This mixture is cooled to rt, and then is poured into ice. Soild K2CO3 is added until the pH of the mixture is basic. The mixture is partitioned between H20 and EtOAc. The two layers is separated, and the aqueous layer is extracted with EtOAc once. The combined organic layers are washed with H2O and brine, dried over MgS04, filtered, and concentrated in vacuo to yield 0.7 g (92percent) of the product a yellow powder. 1H NMR (CDC13, 300 MHz) δ 9.02 (s, 1H), 8.65 (d, J= 5.8, 1 H), 7.04 (d, J = 5.9, 1H), 4.05 (s, 3H). LC Rt: 0.5 min; LCMS m/z 155 (M+l, 100percent).
Reference: [1] Patent: WO2011/78984, 2011, A1, . Location in patent: Page/Page column 62
  • 11
  • [ 620-08-6 ]
  • [ 36057-44-0 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 2, p. 738 - 741
[2] Journal of Organic Chemistry, 2013, vol. 78, # 16, p. 8054 - 8064
[3] Patent: WO2015/66697, 2015, A1,
[4] Patent: WO2015/109109, 2015, A1,
[5] Patent: US2017/44182, 2017, A1,
  • 12
  • [ 620-08-6 ]
  • [ 98303-20-9 ]
Reference: [1] Journal of Organic Chemistry, 1990, vol. 55, # 2, p. 738 - 741
  • 13
  • [ 620-08-6 ]
  • [ 82257-09-8 ]
Reference: [1] Tetrahedron, 1993, vol. 49, # 37, p. 8373 - 8380
[2] Synthesis, 2001, # 14, p. 2175 - 2179
  • 14
  • [ 620-08-6 ]
  • [ 89640-55-1 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: With 2,2,6,6-tetramethyl-piperidine; n-butyllithium; zinc dichloro(N,N,N′,N′-tetramethylethylenediamine) In tetrahydrofuran; hexane at 20℃; for 2 h; Inert atmosphere
Stage #2: With iodine In tetrahydrofuran; hexane at 20℃; Inert atmosphere
General procedure: To a stirred, cooled (0 C) solution of 2,2,6,6-tetramethylpiperidine (0.25 mL, 1.5 mmol) in THF (2-3 mL) were successively added BuLi (about 1.6 M hexanes solution, 1.5 mmol) and, 5 min later, ZnCl2TMEDA[51] (0.13 g, 0.50 mmol). The mixture was stirred for 15 min at 0 C before introduction of the substrate (1.0 mmol) at 0-10 C. After 2 h at room temperature, a solution of I2 (0.38 g, 1.5 mmol) in THF (4 mL) was added. The mixture was stirred overnight before addition of an aqueous saturated solutionof Na2S2O3 (4 mL) and extraction with AcOEt (320 mL). The combined organic layers were dried over MgSO4, filtered and concentrated under reduced pressure. Purification by chromatographyon silica gel (the eluent is given in the product description) led to the compounds described below.
70%
Stage #1: With (THF)Li(TMP)Zn(tBu)2 In tetrahydrofuran at 25℃; for 2 h; Inert atmosphere
Stage #2: With iodine In tetrahydrofuran at 0℃; for 1 h; Inert atmosphere
General procedure: [Li(TMP)Zn(tBu)2] 1 was made according to the literature procedure2 on a 0.4 mmol scale in THF solution. To this solution 2-methoxypyridine (0.042 mL, 0.4 mmol) was added and the resultant light orange reaction allowed to stir at room temperature for 2 hours. Next the solution was cooled to 0°C and quenched with I2 (508 mg, in 1 mL THF) and allowed to stir for 1 hour. Next a 10percent solution of Na2S2O3 was added until bleaching and the product extracted with DCM (3 x 1 mL). The combined organic extracts were dried over MgSO4 and the solvent removed under reduced pressure. The residue was purified by SiO2 chromatography using Heptane:DCM as eluent (20:80-->40:60) to give 3-iodo2-methoxypyridine 2a as a colourless oil (87.1 mg, 92percent yield).
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
[2] Tetrahedron, 1993, vol. 49, # 37, p. 8373 - 8380
[3] Tetrahedron Letters, 2011, vol. 52, # 36, p. 4590 - 4594
[4] Chemical Communications, 2014, vol. 50, # 85, p. 12859 - 12862
[5] Chemistry - A European Journal, 2013, vol. 19, # 24, p. 7944 - 7960
[6] Tetrahedron Letters, 1991, vol. 32, # 42, p. 5919 - 5922
  • 15
  • [ 620-08-6 ]
  • [ 89640-55-1 ]
Reference: [1] Tetrahedron, 2016, vol. 72, # 17, p. 2196 - 2205
  • 16
  • [ 620-08-6 ]
  • [ 68-12-2 ]
  • [ 82257-15-6 ]
YieldReaction ConditionsOperation in experiment
61%
Stage #1: With n-butyllithium; 2,4,6-trimethylphenyl bromide In tetrahydrofuran; pentane at -78 - 20℃; for 1 h;
Stage #2: at -78 - 23℃; for 3 h;
Stage #3: at -78℃; for 1 h;
Example 2 Preparation of 4-Methoxypyridine-3-carboxaldehyde tert-Butyllithium (90.6 mL, 154 mmol ; 1.7 M in pentane) was added via cannula to a stirred solution of tetrahydrofuran (380 mL) under an atmosphere of nitrogen at room temperature. The reaction mixture was cooled to-78 °C before adding 2-bromomesitylene (11.3 mL, 74.1 mmol) dropwise. The reaction mixture was allowed to stir for 1 hour at-78 °C. To the reaction mixture at-78 °C was added 4- methoxypyridine (5.79 mL, 57 mmol) dropwise, and the resulting mixture was stirred at- 23 °C for 3 hours. The reaction mixture was then re-cooled to-78 °C and dimethylformamide (6.62 mL, 85.5 mmol) was added and stirring was continued for 1 hour at-78 °C. The reaction mixture was quenched slowly at-78 °C with saturated aqueous sodium chloride solution (100 mL) and allowed to warm to room temperature slowly. To the reaction mixture was added diethyl ether (200 rnL) and the layers were separated. The aqueous layer was extracted with diethyl ether (2 x 150 mL) and the combined organic layers were dried over potassium carbonate (20 g). The potassium carbonate was removed by filtration and washed with diethyl ether (100 mL) and the solvent removed under reduced pressure. The resulting crude 4-methoxy-3- pyridinecarboxaldehyde was purified by column chromatography (SiO2, 5: 95 ethanol: ethyl acetate) to give 4.79 g of the title intermediate as a yellow solid (61 percent yield; >98percent purity by'H NMR).
47.6%
Stage #1: With 2,4,6-trimethylphenyl bromide; tert.-butyl lithium In tetrahydrofuran at -78 - 20℃; for 3 h; Inert atmosphere
Stage #2: at -78℃; for 1 h; Inert atmosphere
To a solution of t-butyllithium in THF (1.7 M, 9.7 mL, 16.5 mmol, 2.1 eq) in THF (40 mL) maintained at -78 °C was added 2-bromomesitylene (1.6 g, 8.0 mmol, 1.3 eq) dropwise. The resulting solution was stirred for 1 h at -78 °C, then 4-methoxypyridine (681 mg, 0.63 mL, 6.2 mmol) was added and the mixture was warmed to -20 °C in an ice-salt bath. After stirring for 3 h at -20 °C, the mixture was cooled back to -78 °C and DMF (1.17 g, 16.0 mmol, 2.0 eq) was added. The reaction mixture was stirred for 1 h, quenched with brine at -78 °C and extracted with diethyl ether (3 × 100 mL). The combined organic extracts were dried over K2CO3, filtered and evaporated to yield a crude oil that was purified by silica gel chromatography using 1:1 EtOAc:hexanes to yield 405 mg (47.6percent) of product as a pale yellow oil: Rf 0.25 (1:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3) δ 10.43 (s, 1H), 8.87 (s, 1H), 8.62 (d, 1H), 6.92 (d, 1H), 4.1 (s, 3H).
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 1, p. 39 - 41
[2] Tetrahedron Letters, 2000, vol. 41, # 24, p. 4777 - 4780
[3] Patent: WO2005/42514, 2005, A2, . Location in patent: Page/Page column 25
[4] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 419 - 434
[5] Journal of Organic Chemistry, 1990, vol. 55, # 1, p. 69 - 73
[6] Tetrahedron Letters, 1988, vol. 29, # 7, p. 773 - 776
[7] Patent: WO2009/156462, 2009, A2, . Location in patent: Page/Page column 126-127
[8] Biochemistry, 2010, vol. 49, # 49, p. 10421 - 10439
  • 17
  • [ 620-08-6 ]
  • [ 576-83-0 ]
  • [ 594-19-4 ]
  • [ 68-12-2 ]
  • [ 82257-15-6 ]
YieldReaction ConditionsOperation in experiment
61%
Stage #1: at -78℃; for 1 h;
Stage #2: at -78 - 23℃; for 4 h;
TERT-BUTYLLITHIUM (90.6 mL, 154 mmol; 1.7 M in pentane) was added via cannula to a stirred solution of tetrahydrofuran (380 mL) under an atmosphere of nitrogen at room temperature. The reaction mixture was cooled to-78°C before adding 2-bromomesitylene (11.3 mL, 74.1 mmol) dropwise. The reaction mixture was allowed to stir for 1 hour at- 78°C. To the reaction mixture at-78°C was added 4-methoxypyridine (5.79 ML, 57 mmol) dropwise, and the resulting mixture was stirred AT-23°C for 3 hours. The reaction mixture was then re-cooled to-78°C and DIMETHYLFORMAMIDE (6.62 mL, 85.5 mmol) was added and stirring was continued for 1 hour AT-78°C. The reaction mixture was quenched slowly AT-78°C with saturated aqueous sodium chloride solution (100 mL) and allowed to warm to room temperature slowly. To the reaction mixture was added diethyl ether (200 mL) and the layers were separated. The aqueous layer was extracted with diethyl ether (2 x 150 mL) and the combined organic layers were dried over potassium carbonate (20 g). The potassium carbonate was removed by filtration and washed with diethyl ether (100 mL) and the solvent removed under reduced pressure. The resulting crude 4-methoxy-3- pyridinecarboxaldehyde was purified by column chromatography (SiO2, 5: 95 ethanol: ethyl acetate) to give 4.79 g of the title intermediate as a yellow solid (61percent yield; >98percent purity by'H NMR). Analytical Data : HNMR (300 MHz, CDCL) 8 10.43 (s, 1H, CHO), 8.87 (s, 1H, ArH), 8.63 (d, 1H, J= 6, ARH), 6.92 (d, 1H, J= 6, ART), 3.98 (s, 3H, CH30).
Reference: [1] Patent: WO2004/41806, 2004, A2, . Location in patent: Page 65
  • 18
  • [ 620-08-6 ]
  • [ 109613-97-0 ]
Reference: [1] Patent: WO2011/78984, 2011, A1,
  • 19
  • [ 620-08-6 ]
  • [ 107512-35-6 ]
Reference: [1] Tetrahedron, 1993, vol. 49, # 37, p. 8373 - 8380
  • 20
  • [ 620-08-6 ]
  • [ 120277-47-6 ]
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 1, p. 39 - 41
  • 21
  • [ 620-08-6 ]
  • [ 501-53-1 ]
  • [ 185847-84-1 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 19, p. 7715 - 7720
[2] Synthesis (Germany), 2017, vol. 49, # 20, p. 4606 - 4612
[3] MedChemComm, 2017, vol. 8, # 4, p. 755 - 766
[4] Organic Letters, 2012, vol. 14, # 7, p. 1842 - 1845
[5] Chemical Communications, 2005, # 13, p. 1711 - 1713
  • 22
  • [ 620-08-6 ]
  • [ 193480-28-3 ]
Reference: [1] Organic letters, 2000, vol. 2, # 23, p. 3679 - 3681
  • 23
  • [ 620-08-6 ]
  • [ 865-47-4 ]
  • [ 676-58-4 ]
  • [ 190906-92-4 ]
YieldReaction ConditionsOperation in experiment
47%
Stage #1: With phenyl chloroformate In tetrahydrofuran at -40℃; for 0.25 h;
Stage #2: at -40 - 20℃; for 0.5 h;
A solution of 5 mL (49 mMol) 4-methoxypyridine in 200 mL tetrahydrofuran was cooled to -40°C, and then 6.9 mL (55 mMol) phenyl chloroformate were added dropwise. After stirring for 15 minutes, 20 mL (60 mMol) methyl magnesium chloride (3M in tetrahydrofuran) were added dropwise and the reaction mixture was allowed to warm to room temperature. After stirring for 30 minutes, the reaction mixture was cooled to -40°C and treated with 340 mMol potassium tert-butoxide. The reaction mixture was allowed to warm to room temperature. After stirring for 1 hour, the reaction mixture was cooled to -40°C and was treated with. 200 mL saturated aqueous oxalic acid. The reaction was warmed to 20°C and allowed to stir for 1 hour. The mixture was extracted 2 x 200 mL diethyl ether. The combined organic phases were washed sequentially with 4 x 100 mL 0.5 N sodium hydroxide, 2 x 100 mL saturated aqueous sodium bicarbonate, 3 x 100 mL deionized water, and 100 mL saturated aqueous sodium chloride. The remaining organics were dried over magnesium sulfate and concentrated under reduced pressure. The residue was subjected to silica gel chromatography, eluting with hexanes containing 40percent ethyl acetate. Fractions containing product were combined and concentrated under reduced pressure to provide 4.9 gm (47percent) 1-(tert-butoxycarbonyl)-2-methyl-4-oxopiperidine. EA: Calculated for: C11H17NO3: C, 62.54; H, 8.11; N, 6.63. Found: C, 62.78; H, 8.08; N, 6.76. A solution of 1.65 gm (7.81 mmol) 1-(tert-butoxycarbonyl)-2-methyl-4-oxopiperidine in 20 mL tetrahydrofuran was cooled to -40°C and was then treated with 8.59 mL (8.59 mMol) lithium tri(sec-butyl)borohydride (1M in tetrahydrofuran). After stirring for 2 hours, the solution was treated with 3.37 gm (8.59 mMol) 2-[N,N-bis(trifluoromethylsulfonyl)amino]-5-chloropyridine and the solution was allowed to warm to room temperature. After stirring for 1 hour, the reaction was diluted with 250 ml diethyl ether and filtered through celite. The celite pad was rinsed with 250 mL diethyl ether and the combined filtrates concentrated under reduced pressure. The residue was subjected to silica gel chromatography, eluting with hexanes containing from 0-9percent ethyl acetate. Fractions containing product were combined and concentrated under reduced pressure to provide 2.02 gm (75percent) of the title compound. ISMS: m/e = 346 (M+H)
Reference: [1] Patent: EP1204660, 2004, B1, . Location in patent: Page 17
  • 24
  • [ 620-08-6 ]
  • [ 190906-92-4 ]
Reference: [1] Patent: CN103601669, 2016, B,
  • 25
  • [ 620-08-6 ]
  • [ 865996-16-3 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 19, p. 7715 - 7720
  • 26
  • [ 620-08-6 ]
  • [ 175965-83-0 ]
Reference: [1] Science, 2013, vol. 342, # 6161, p. 956 - 960
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 620-08-6 ]

Ethers

Chemical Structure| 442126-28-5

[ 442126-28-5 ]

2-(Pyridin-4-yloxy)ethanamine dihydrochloride

Similarity: 0.86

Chemical Structure| 4783-86-2

[ 4783-86-2 ]

4-Phenoxypyridine

Similarity: 0.86

Chemical Structure| 24103-75-1

[ 24103-75-1 ]

4-Methoxy-2-methylpyridine

Similarity: 0.84

Chemical Structure| 109613-93-6

[ 109613-93-6 ]

3,4-Dimethoxypyridine

Similarity: 0.82

Chemical Structure| 120277-47-6

[ 120277-47-6 ]

(4-Methoxypyridin-3-yl)methanol

Similarity: 0.80

Related Parent Nucleus of
[ 620-08-6 ]

Pyridines

Chemical Structure| 626-64-2

[ 626-64-2 ]

Pyridin-4-ol

Similarity: 0.92

Chemical Structure| 442126-28-5

[ 442126-28-5 ]

2-(Pyridin-4-yloxy)ethanamine dihydrochloride

Similarity: 0.86

Chemical Structure| 4783-86-2

[ 4783-86-2 ]

4-Phenoxypyridine

Similarity: 0.86

Chemical Structure| 24103-75-1

[ 24103-75-1 ]

4-Methoxy-2-methylpyridine

Similarity: 0.84

Chemical Structure| 109613-93-6

[ 109613-93-6 ]

3,4-Dimethoxypyridine

Similarity: 0.82